Lupin Receives Tentative Approval for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL
Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL, Unit-dose Vials are indicated for the long-term maintenance…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
MoHFW seeks export ban of anti-TB drugs
Delay in production and receipt of supply may cause acute shortage of these drugs, highlights Union Health Secretary
Lupin’s Mandideep Unit II Facility Receives EIR from US FDA
The inspection at the facility was carried out by the US FDA between November 26, 2018 and December 4, 2018
Lupin’s Nagpur Facility Receives EIR from US FDA
The inspection for the facility was carried out by the US FDA between January 6, 2020 and January 10, 2020
Lupin contributes Rs 21 crores towards COVID-19 relief efforts
The contributions were made separately by Lupin’s employees, the Company and the promoter family
Lupin launches Mycophenolic Acid Delayed-Release Tablets USP
Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg, is the generic equivalent of Myfortic Delayed-Release Tablets,…
Lupin’s Aurangabad Facility Receives EIR from US FDA
The inspection for the facility was carried out between February 10, 2020 and February 14, 2020 and concluded with no observations
Lupin’s Inhalation Research Center, Florida receives EIR from US FDA
Lupin’s Inhalation Research Center at Coral Springs, Florida focuses on research and development of respiratory products for the…
Lupin appoints Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs
Ramesh will lead Lupin’s Finance, Investor Relations, Strategic Planning, Information Technology, Corporate Communications and…
Lupin receives ISRS Certification, 8th Edition
The certification was received after audits were conducted at four of the company’s manufacturing facilities Lupin has received…